Prot#M19-148: A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic Stroke

Project: Research project

Project Details

StatusFinished
Effective start/end date10/10/2010/10/23

Funding

  • AbbVie Inc. (Prot#M19-148)